I am more excited re Admedus in the past 3 months. They have gone from a sophisticated sausage skin for medical purposes to a highly tailored medical products company. We have two ply products. We have Neo products which are of a brand. We have 3d products and 3d printing products. We have advanced and progressed in the sophisticated medical sphere. I believe that we should concentrate in the neonatal area.We have the products to supply the market in this area which commands a brand premium price. If we could supply 50 to 100 of the worlds neonatal cardiac centres with our premium products we would be highly profitable. Europe is untouched presently. Get EU approval and enjoy the results.
I believe that WP can partner with the likes of Merck for our HPV work and get even a 10 to 20m signing fee and a 5 to 10 % share of the future profits. The rest of the products could trickle in with $1m contributions. China and India would be the future booster rockets. Just my present thoughts.
AHZ-- 100 baggers, page-73
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.90 |
Change
1.050(9.68%) |
Mkt cap ! $251.5M | |||
| Open | High | Low | Value | Volume |
| $11.00 | $11.90 | $10.85 | $504.4K | 45.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $11.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.90 | 99 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |